BamSEC and AlphaSense Join Forces
Learn More

MaxCyte Inc.

NASDAQ: MXCT    
Share price (6/10/25): $2.31    
Market cap (6/10/25): $246 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Earnings Revised 05/19/25 MaxCyte, Inc., Q1 2025 Earnings Call, May 07, 2025 05/07/25 Earnings Revised 03/25/25 MaxCyte, Inc., Q4 2024 Earnings Call, Mar 11, 2025 03/11/25
CY 2024
Earnings Revised 01/07/25 MaxCyte, Inc., Q3 2024 Earnings Call, Nov 06, 2024 11/06/24 Earnings Revised 08/30/24 MaxCyte, Inc., Q2 2024 Earnings Call, Aug 06, 2024 08/06/24 Earnings Revised 06/11/24 MaxCyte, Inc., Q1 2024 Earnings Call, May 07, 2024 05/07/24 Earnings Revised 03/12/24 MaxCyte, Inc., 2023 Earnings Call, Mar 12, 2024 03/12/24
CY 2023
Earnings Revised 11/09/23 MaxCyte, Inc., Q3 2023 Earnings Call, Nov 08, 2023 11/08/23 Other Revised 10/04/23 MaxCyte, Inc., Q3 2023 Sales/ Trading Statement Call, Oct 04, 2023 10/04/23 Earnings Revised 08/10/23 MaxCyte, Inc., Q2 2023 Earnings Call, Aug 09, 2023 08/09/23 Earnings Revised 06/15/23 MaxCyte, Inc., Q1 2023 Earnings Call, May 10, 2023 05/10/23 Earnings Revised 03/15/23 MaxCyte, Inc., Q4 2022 Earnings Call, Mar 15, 2023 03/15/23
CY 2022
Earnings Revised 11/09/22 MaxCyte, Inc., Q3 2022 Earnings Call, Nov 09, 2022 11/09/22 Other Revised 09/13/22 MaxCyte, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 04:40 PM 09/13/22 Earnings Revised 08/10/22 MaxCyte, Inc., Q2 2022 Earnings Call, Aug 10, 2022 08/10/22 Other Revised 05/11/22 MaxCyte, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 04:40 PM 05/11/22 Earnings Revised 05/09/22 MaxCyte, Inc., Q1 2022 Earnings Call, May 09, 2022 05/09/22 Earnings Revised 03/22/22 MaxCyte, Inc., Q4 2021 Earnings Call, Mar 22, 2022 03/22/22 Other Revised 02/07/22 MaxCyte, Inc. - Shareholder/Analyst Call 02/07/22
CY 2021
Earnings Revised 11/10/21 MaxCyte, Inc., Q3 2021 Earnings Call, Nov 10, 2021 11/10/21 Earnings Revised 09/13/21 MaxCyte, Inc., Q2 2021 Earnings Call, Sep 13, 2021 09/13/21 Other Revised 01/20/21 MaxCyte, Inc., 2020 Sales/ Trading Statement Call, Jan 20, 2021 01/20/21